July 17, 2025 | Aclymate, Carbon Emissions, Carbon footprint, Hybrid Events, Hybrid meetings, Impetus Digital, Pharma meetings, Sustainability, carbon neutral, green pharma, pharma vvents, reduce carbon, sustainable pharma
Impetus Digital was promoted to the Aclymate Silver Tier for their efforts in crafting carbon-neutral virtual and live meetings for life science companies.

A year after Impetus Digital first calculated and offset all of our home office-related emissions, we’re excited to announce that we have now implemented Phase 2 of our journey toward carbon neutrality. As of January 2024, all of the carbon emissions associated with Impetus Digital staff attending hybrid meetings live (i.e., flights, ground transportation for local meetings, and accommodation) have been–and will continue to be–offset. This means that–while we still encourage clients to go fully virtual to cut down on their meeting-associated emissions almost entirely–those opting for a hybrid event can still feel good knowing that any Impetus support staff attending the meeting in person is not contributing to the carbon footprint of the event.
In fact, we were recently promoted to the Aclymate Silver Tier for our efforts to date. Plus, we continue to be platinum-certified by the Green Business Benchmark (GBB), demonstrating our commitment to sustainable practices!
Phase 3 and beyond will involve calculating and offsetting the emissions associated with the actual meeting venues, any Impetus business trips for reasons other than attending live client meetings and events (e.g., conference attendance), and the small but non-negligible emissions associated with our online portals. Stay tuned for more updates!
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate…
Samantha Lippolis, Telehealth Advisor at Sam I am Innovates; Dr. Daniel Fagbuyi, CEO of Erudition; Dr. Brian Block, Health Care Consultant at Brian Block Consulting; Mindy Klowden, Director of Strategic Initiatives at the Colorado Behavioral Healthcare…
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding…
Justin Sutherland, Co-founder and President of Realize Medical, delves into a range of topics around virtual reality (VR) and three-dimensional modeling, including the roles of VR in medical education, training, surgery planning,…
Peter Birch, General Manager (Asia Pacific) at MetaOptima Technologies & host of the “Talking HealthTech Podcast.” joins us to discuss a whole range of topics, including Peter’s professional journey and the…
Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an…
Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk’s Neuralink and the Future of the Computer Brain Interface.
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians.
Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many…


